You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available
Part (v) New inpatient clients, age distribution by primary drug (%)
| Substance | <15 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45+ | Mean age | Age known (base) | Age not known |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opioids | 0.1 | 6.9 | 20.7 | 27.9 | 20.3 | 11.8 | 6.6 | 5.7 | 30.1 | 3862 | 1 |
| Cocaine | 0.0 | 3.6 | 18.6 | 28.2 | 20.6 | 15.5 | 8.0 | 5.5 | 31.1 | 724 | 0 |
| Stimulants | 0.5 | 16.5 | 32.9 | 23.7 | 12.3 | 5.4 | 3.0 | 5.7 | 26.9 | 1297 | 6 |
| Hypnotics and sedatives | 0.0 | 2.2 | 13.0 | 13.3 | 11.6 | 11.3 | 9.4 | 39.3 | 37.6 | 415 | 1 |
| Hallucinogens | 0.0 | 7.4 | 29.6 | 24.7 | 18.5 | 9.9 | 4.9 | 4.9 | 28.9 | 81 | 0 |
| Volatile substances | 6.0 | 50.9 | 17.5 | 12.8 | 6.0 | 3.8 | 2.1 | 0.9 | 21.9 | 234 | 1 |
| Cannabis | 1.1 | 24.7 | 30.3 | 17.9 | 12.6 | 6.0 | 3.9 | 3.5 | 25.9 | 1879 | 0 |
| Other substances | 1.4 | 16.5 | 23.3 | 21.7 | 9.5 | 6.6 | 4.4 | 16.5 | 29.6 | 497 | 1 |
| Total | 0.6 | 13.2 | 24.1 | 23.8 | 16.2 | 9.4 | 5.5 | 7.2 | 28.9 | 8989 | 10 |
Notes
The countries supplying data are:
AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.
The number of treatment clients in each country is listed in Table TDI-7.
See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.